DiaSorin shares plunge 17% as 2026 margin outlook shadows FY25 earnings
Investing.com Gold reports: DiaSorin shares plunge 17% as 2026 margin outlook shadows FY25 earnings. This is a premium/paywalled source, so the brief is based on headline and available metadata only.